An important step on the long path to clinical application of in utero gene therapy

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.


  1. 1.

    Coutelle C, Douar A-M, College WH, Froster U. The challenge of fetal gene therapy. Nat Med. 1995;1:864–6.

  2. 2.

    Waddington SN, Kennea NL, Buckley SM, Gregory LG, Themis M, Coutelle C. Fetal and neonatal gene therapy: benefits and pitfalls. Gene Ther. 2004;11 Suppl 1:S92–7.

  3. 3.

    David AL, Themis M, Waddington S, Gregory L, Buckley S, Nivsarkar M, et al. The current status and future direction of fetal gene therapy. Gene Ther Mol Biol. 2003;7:181–209.

  4. 4.

    Coutelle C, Themis M, Waddington SN, Buckley SM, Gregory LG, Nivsarkar MS, et al. Gene therapy progress and prospects: fetal gene therapy - first proofs of concept- some adverse effects. Gene Ther. 2005;12:1601–7.

  5. 5.

    Waddington S, Nivsarkar M, Mistry A, Buckley SMK, Al-Allaf F, Bigger, et al. Permanent phenotypic correction of Haemophilia B in immunocompetent mice by prenatal gene therapy. Blood. 2004;104:2714–21.

  6. 6.

    Themis M, Waddington SN, Schmidt M, von Kalle C, Wang Y, Al-Allaf F. Oncogenesis following delivery of a non-primate lentiviral gene therapy vector to fetal mice. Mol Ther. 2005;12:763–71.

  7. 7.

    Mattar CN, Nathwani AC, Waddington SN, Dighe N, Kaeppe C, Nowrouzi A, et al. Stable human FIX expression after 0.9G intrauterine gene transfer of self-complementary adeno-associated viral vector 5 and 8 in macaques. Mol Ther. 2011;19:1950–60.

  8. 8.

    Almeida-Porada G, Atala A, Porada CD. In utero stem cell transplantation and gene therapy: rationale, history, and recent advances toward clinical application. Mol Ther Methods Clin Dev. 2016;5:16020.

  9. 9.

    David AL. Maternal uterine artery VEGF gene therapy for treatment of intrauterine growth restriction. Placenta. 2017;59 Suppl 1:S44–S50.

  10. 10.

    Massaro G, Mattar CNZ, Wong AMS, Sirka E, Buckley SMK, Herbert BR. et al.Fetal gene therapy for neurodegenerative disease of infants.Nat Med. 2018;24:1317–23.

  11. 11.

    Mignot C, Gelot A, Bessières B, Daffos F, Voyer M, Menez F, et al. Perinatal-Lethal Gaucher disease. Am J Med Genet. 2003;120A:338–44.

  12. 12.

    Coutelle C, Ashcroft R. Risks, benefits and ethical, legal, and societal considerations for translation of prenatal gene therapy to human application. Methods Mol Biol. 2012;891:371–87.

  13. 13.

    Schneider H, Faschingbauer F, Schuepbach-Mallepell S, Körber I, Wohlfart S, Dick A, et al. Prenatal correction of X-linked hypohidrotic ectodermal dysplasia. N Engl J Med. 2018;378:1604–10.

Download references

Author information

Correspondence to Charles Coutelle.

Ethics declarations

Conflict of interest

The author declares that he has no conflict of interest.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark